The Global Hematologic Malignancies Therapeutics Market Size was valued at USD 40.4 Billion in 2017 and is anticipated to reach USD 87.0 Billion by 2025. This growth is driven by the rising incidences of lifestyle-related diseases with North America region currently dominating the market followed by Asia-Pacific.
read more..